Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal
2018 · Cell · 835 citations
https://doi.org/10.1016/j.cell.2018.03.057
H
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
186
Papers
10.6K
Citations
33
h-index
84
i10-index
Hang Xu is an academic researcher from Chinese Academy of Medical Sciences & Peking Union Medical College. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Bladder and Urothelial Cancer Treatments & Melanoma and MAPK Pathways. The author has an h-index of 33, co-authored 159 publications.
ORCID: 0000-0002-5847-655XPapers by this author
worksTiming the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal
2018 · Cell · 536 citations
https://doi.org/10.1016/j.cell.2018.02.020
Selection of metastasis competent subclones in the tumour interior
2021 · Nature Ecology & Evolution · 99 citations
https://doi.org/10.1038/s41559-021-01456-6
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity
2020 · Nature Communications · 95 citations
https://doi.org/10.1038/s41467-020-17526-5
Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue
2020 · Cell Reports · 71 citations
https://doi.org/10.1016/j.celrep.2020.107550
Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carcinoma
2021 · Molecular Cancer · 70 citations
https://doi.org/10.1186/s12943-021-01465-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat